Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose vs Iron Sucrose for Iron Deficiency Anemia in Chinese Subjects
NCT03591406Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Jul 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by CSL Vifor. Started Jul 2017; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03591406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591406.